New York, New York, United StatesFounded 20197+ employeesPrivate
$4.1M raisedSeed· last: seed (Feb 2025)· 4 rounds
Backed by(8 investors)
Humane Genomics is developing a platform to engineer cancer killing viruses with unprecedented specificity and efficiency. Our first indication is liver cancer. We are based in New York City and backed by amazing investors. (YC S21)
